 |
| Charlie Chapman |
Charlie Chapman, a policy advisor to Health & Human Services Secretary Robert F. Kennedy Jr. has joined BGR’s health & life sciences practice.
He provided counsel to Kennedy on policy and operational issues related to the Centers for Medicare and Medicaid Services.
Chapman also coordinated DHHS activities with the White House and Office of Management and Budget, and represented Kennedy before corporate leaders and state/local government officials.
Prior to joining the Trump II administration, Chapman was a staffer on the Budget Committee, where he helped craft the healthcare provisions of the One Big Beautiful Bill Act.
As VP at BGR, Chapman will counsel clients as they navigate changes to health care coverage and payment policies.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
